Drug Type Small molecule drug |
Synonyms VRN 14, VRN14 |
Target |
Mechanism Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | 13 Sep 2022 | |
Neoplasms | Preclinical | KR | 13 Sep 2022 |